We investigated a hospital-based series of 40 consecutive patients with triple-negative breast cancer for mutations in the whole coding sequences of BRCA1 and BRCA2 as well as in the two genes PALB2 and BRD7, which encode interaction partners of the BRCA1 protein. The gene discussed is BRD7; the disease is triple-negative breast carcinoma.